PSA (biochemical)
Showing 1 - 25 of 3,679
Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],
Recruiting
- Urologic Cancer
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- Pembrolizumab Injection [Keytruda]
- Salvage Radiation Therapy (SRT)
-
Freiburg, Baden-Württemberg, GermanyClinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022
Prostate Cancer Trial in Myrtle Beach (ChAdOx1-PCAQ, MVA-PCAQ)
Recruiting
- Prostate Cancer
- ChAdOx1-PCAQ
- MVA-PCAQ
-
Myrtle Beach, South CarolinaCarolina Urologic Research Center
Jan 30, 2023
Molecular Forms of PSA and Human Kallikrein 2 inCohort of
Active, not recruiting
- Prostate Cancer
- blood draw
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 1, 2022
Prostate Cancer Trial in Lexington (ArtemiCoffee)
Not yet recruiting
- Prostate Cancer
-
Lexington, KentuckyUniversity of Kentucky
Jul 25, 2022
Biochemical Relapse Fo Malignant Tumor of Prostate Trial in Taipei (18F-FACBC PET/CT)
Recruiting
- Biochemical Relapse Fo Malignant Neoplasm of Prostate
- 18F-FACBC PET/CT
-
Taipei, TaiwanNational Taiwan University Hospital
Sep 8, 2021
Prostate Adenocarcinoma, PSA Level Greater Than 0.2, PSA Level Greater Than or Equal to Two Trial in Palo Alto (procedure,
No longer available
- Prostate Adenocarcinoma
- +4 more
- Computed Tomography
- +3 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Jan 6, 2022
Prostatic Tumors, Prostate Cancer, Recurrence Trial in France, Spain, Switzerland ([18F]CTT1057, [68Ga]Ga-PSMA-11)
Recruiting
- Prostatic Neoplasms
- +2 more
-
Marseille Cedex 05, France
- +8 more
Aug 9, 2022
Prostate Adenocarcinoma, PSA Progression, Recurrent Prostate Carcinoma Trial in Palo Alto (Gallium Ga 68 DOTA-NeoBOMB1, Gallium
Suspended
- Prostate Adenocarcinoma
- +2 more
- Gallium Ga 68 DOTA-NeoBOMB1
- Gallium Ga 68 PSMA-R2
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
May 3, 2022
Biochemical Recurrence of Malignant Tumor of Prostate, Prostate Cancer, BCR Prostate Carcinoma Trial in China (68Ga-PSMA-11,
Not yet recruiting
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- +2 more
- 68Ga-PSMA-11
- PET/CT or PET/MRI
-
Changsha, China
- +5 more
Apr 26, 2023
Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)
Recruiting
- Prostate Cancer
- Biochemical Recurrence
- Rezvilutamide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 2, 2023
Prostatic Tumors Trial in Kfar-Saba (PectaSol-C Modified Citrus Pectin (MCP))
Completed
- Prostatic Neoplasms
- PectaSol-C Modified Citrus Pectin (MCP)
-
Kfar-Saba, IsraelGenitourinary Oncology Service, Institute of Oncology, Meir Medi
Jan 27, 2020
After Radical Prostatectomy for Prostate Cancer: Comparing Open
Completed
- Prostate Cancer
-
Ghent, BelgiumGhent University Hospital
Jan 2, 2023
Prostate Cancer, Salvage Radiotherapy, Biochemical Recurrence Trial (triptorelin, goserelin, leuprorelin)
Not yet recruiting
- Prostate Cancer
- +4 more
- triptorelin, goserelin, leuprorelin
- (no location specified)
Mar 10, 2023
Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)
Terminated
- Adenocarcinoma of the Prostate
- Muscadine Plus
- Placebos
-
Duarte, California
- +12 more
Dec 6, 2022
Prostate Cancer Trial (Early salvage radiotherapy (eSRT), Delayed Salvage radiotherapy (dSRT))
Not yet recruiting
- Prostate Cancer
- Early salvage radiotherapy (eSRT)
- Delayed Salvage radiotherapy (dSRT)
- (no location specified)
Aug 2, 2022
Cancer of Prostate Trial in Ann Arbor (ADT ORDER CHECK ATTESTATION (OR), PROVIDER SCRIPT (SC))
Active, not recruiting
- Cancer of Prostate
- ADT ORDER CHECK ATTESTATION (OR)
- PROVIDER SCRIPT (SC)
-
Ann Arbor, MichiganVA Ann Arbor Healthcare System
Nov 7, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Los
Terminated
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 19, 2022
Prostate Cancer Trial run by the National Cancer Institute (NCI) (PROSTVAC-V, PROSTVAC-F, MSB0011359C (M7824))
Recruiting
- Prostate Cancer
- PROSTVAC-V
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Prostate Cancer Trial in Beijing (Darolutamide+ADT)
Not yet recruiting
- Prostate Cancer
-
Beijing, ChinaPeking University First Hospital
Sep 1, 2023
Psoriatic Arthritis, Obesity Trial in Ankara (diet and biopsychosocial exercise intervention)
Completed
- Psoriatic Arthritis
- Obesity
- diet and biopsychosocial exercise intervention
-
Ankara, TurkeySümeyra Öteleş
Dec 4, 2022
Cancer of Prostate Trial in Bethesda, Philadelphia (Observation and Bicalutamide, Metformin and Bicalutamide)
Completed
- Cancer of Prostate
- Observation and Bicalutamide
- Metformin and Bicalutamide
-
Bethesda, Maryland
- +1 more
Mar 2, 2022
Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)
Recruiting
- Biochemical Recurrent Prostate Cancer
- Radium-223
- 18F Sodium Fluoride
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Prostate Cancer Trial in Milwaukee (Pacritinib)
Recruiting
- Prostate Cancer
-
Milwaukee, WisconsinFroedtert & the Medical College of Wisconsin
Jul 18, 2022